Online GLP-1 programs often look easier to compare than they really are. One provider advertises a low monthly medication price, another separates the prescription from a membership charge, and a third may offer both compounded and FDA-approved products under very different payment structures.
MEDVi is a telehealth platform that coordinates online medical evaluation, prescription treatment where clinically appropriate, pharmacy fulfillment and continuing support. Its convenience and advertised compounded-medication prices may appeal to self-pay patients, but the details require careful reading. Prices differ across MEDVi landing pages, compounded and brand-name options do not have the same regulatory status, and monthly charges are subject to specific cancellation rules.
Key takeaways
- MEDVi advertises compounded semaglutide and tirzepatide injections, oral GLP-1 products and separate pathways for FDA-approved brand-name medications. Availability and prescribing depend on an independent clinician’s evaluation.
- The lowest prices reviewed were associated with compounded injections. Brand-name Wegovy and Zepbound were presented under a separate membership-plus-medication model.
- Pricing is not fully consistent across MEDVi’s current landing pages. Consumers should rely on a written checkout summary showing the formulation, monthly renewal price and what is included.
- MEDVi lists several partner pharmacies and states that it does not produce the compounded medication itself. The pharmacy that will dispense an individual prescription should still be confirmed before treatment.
- The FDA sent MEDVi a warning letter in February 2026 concerning earlier claims and labeling for compounded semaglutide and tirzepatide. Current MEDVi pages now state that compounded products are not FDA approved and that MEDVi is not the compounder.
- Cancellations must generally be requested at least 72 hours before the next billing date. Monthly charges are usually nonrefundable once billed, except in limited circumstances such as medical disqualification.
MEDVi at a glance
| Review category | What we found |
|---|---|
| Care model | Fully online intake, independent clinician review, prescribing when appropriate, pharmacy fulfillment and ongoing portal support |
| Medication pathways | Compounded semaglutide and tirzepatide injections, oral GLP-1 products and separately priced brand-name options |
| Lowest advertised pricing reviewed | Some pages showed price-locked compounded injections from $116 for semaglutide and $166 for tirzepatide; other pages displayed different starting prices |
| Medication included? | Generally represented as included for compounded subscription pathways; brand-name pathways list membership plus medication cost |
| Insurance | Primarily positioned as self-pay; affiliated medical providers are described as out of network |
| Pharmacy disclosure | MEDVi publicly lists Triad Rx, Red Rock Pharmacy and Beaker Pharmacy & Compounding as partners |
| Follow-up | Portal management, messaging, provider guidance and advertised 24/7 support |
| Cancellation | At least 72 hours before the next billing date to avoid another billing cycle |
| Major limitation | Conflicting advertised prices and important differences between compounded and FDA-approved treatment |
Information checked August 5, 2026. Pricing, availability, pharmacies and program policies may change.
What is MEDVi?
MEDVi is the administrative telehealth platform rather than the medical practice or pharmacy. Its terms state that independent medical professionals affiliated with provider networks deliver the clinical care, while MEDVi handles technology, records, scheduling, payment coordination and optional prescription fulfillment. MEDVi’s public materials identify CareGLP-affiliated professional entities and OpenLoop Health in connection with medical services.
That distinction matters. Completing MEDVi’s intake does not automatically create a doctor-patient relationship or guarantee a prescription. The company says an OpenLoop clinician evaluates the patient after checkout and retains independent authority over whether compounded GLP-1 treatment is appropriate.
How the MEDVi weight-loss process works
The published process follows a familiar telehealth sequence:
- Complete an online intake. You provide information about your health history, current medications, location, weight and treatment goals.
- Pay for the selected subscription pathway. MEDVi’s cancellation policy says the subscription begins after the intake and first payment.
- Meet or communicate with a licensed provider. The clinician reviews your information and decides whether medication is appropriate.
- Receive a prescription if eligible. The medication and formulation depend on the provider’s judgment, availability and the selected program.
- Pharmacy fulfillment and delivery. The prescription is sent to a pharmacy and shipped to the patient.
- Continue monitoring and refills. MEDVi advertises portal-based progress tracking, clinician communication, coaching and ongoing support.
A useful question is whether the first consultation will be live by video or handled partly through asynchronous forms and messaging. MEDVi’s refund policy says included consultations may be live or conducted through electronic submissions and provider review, suggesting the format can vary.
Which medications does MEDVi offer?
MEDVi’s public pages advertise weekly semaglutide and tirzepatide injections, daily dissolvable GLP-1 tablets, a Wegovy pill pathway and brand-name Wegovy and Zepbound injections. One separate page also advertises Ozempic. The options shown to a particular patient may depend on location, medical history and availability.
Compounded medication is not generic medication
MEDVi’s lower-priced injection programs appear to be associated with compounded GLP-1 treatment. A compounded preparation is made for an individual prescription through an eligible pharmacy or outsourcing facility. It is not an FDA-approved generic equivalent of Wegovy, Ozempic, Mounjaro or Zepbound.
The FDA does not review a compounded drug’s finished formulation for safety, effectiveness or quality before marketing. Compounding can address a legitimate patient-specific need, but it should not be presented as automatically equivalent to an approved medication.
The regulatory environment is also changing. In April 2026, the FDA reminded compounders that they generally cannot regularly produce drugs that are essentially copies of commercially available products unless applicable legal conditions are met. That means the continued availability or formulation of compounded semaglutide and tirzepatide can change.
MEDVi separately lists a generic-sounding “GLP-1 tablet” and a branded Wegovy pill pathway. Patients should ask for the exact drug name, formulation, manufacturer or compounder and FDA-approval status rather than assuming all oral semaglutide products are interchangeable.
How much does MEDVi cost?
The most significant pricing finding is inconsistency between official MEDVi pages.
| MEDVi pathway | Advertised information reviewed |
| Compounded semaglutide injection | $116 per month on one price-lock page; $179 starting price on another landing page |
| Compounded tirzepatide injection | $166 per month on one price-lock section; another section on the same page referred to $199 |
| GLP-1 tablets | A separate page listed a $249 starting price; another contained an unpopulated price field |
| Wegovy pill | $99 membership plus medication cost |
| Wegovy or Zepbound injection | $99 membership plus medication cost; availability subject to change |
| Ozempic | One landing page displayed a starting price of $1,999 per month |
These were advertised figures, not a personalized checkout quote.
The mixed figures do not necessarily mean every patient is charged unpredictably. They may reflect separate promotions, campaigns, formulations or pricing tests. However, they make it essential to obtain a written summary that answers:
- Is this the first-month price or the ongoing renewal price?
- Is the medication compounded or FDA approved?
- Are all dosages included at the same rate?
- Does the price include the consultation, supplies and shipping?
- Is a membership charge added separately?
- Will the pharmacy or prescribed product affect the final charge?
MEDVi’s terms specifically state that the final card charge may fluctuate depending on the prescribed medication and fulfillment pharmacy, although the company says support will communicate a variance. This deserves clarification whenever a landing page promises a locked price.
Does MEDVi accept insurance?
MEDVi is principally positioned as a self-pay service. Its terms say affiliated providers are out of network with commercial and government health plans and that prescriptions or laboratory services may not be covered. Some pages state that insurance is not required and advertise HSA or FSA eligibility.
The website also advertises dietitian visits, but its footnote says free access may depend on insurance and copay eligibility. Confirm whether nutrition visits are included in the subscription, submitted to insurance or subject to an additional copay.
Clinical support and pharmacy transparency
MEDVi advertises one-to-one provider guidance, portal messaging, progress tracking, care coaching and 24/7 support. Some pages describe physicians and nurses as available around the clock. Prospective members should ask whether “24/7 support” means immediate access to a prescribing clinician, a nursing service, administrative support or a message that will be answered later.
The company’s pharmacy disclosure is more specific than that of many telehealth landing pages. MEDVi publicly lists Triad Rx in Alabama, Red Rock Pharmacy in Utah and Beaker Pharmacy & Compounding in Texas as partner pharmacies. It also explains that MEDVi itself is not the pharmacy.
That list is useful, but patients should still confirm the pharmacy printed on their own prescription. A pharmacy may need licenses or nonresident permits in the patient’s state, and pharmacy assignments can change.
Potential benefits
MEDVi may appeal to consumers who value:
- A remote intake and consultation process
- Medication, clinical access and shipping coordinated in one system
- A self-pay route that does not depend on insurance approval
- Both compounded and brand-name pathways
- Public identification of several pharmacy partners
- Portal-based follow-up and coaching
- A refund if the clinician determines that the applicant is medically ineligible before treatment
Its pricing could be competitive when a genuine locked rate includes medication, consultations, supplies and shipping. The difficulty is confirming which published offer applies.
Limitations and trust considerations
The FDA issued MEDVi a warning letter
On February 20, 2026, the FDA sent MEDVi a warning letter based on website content reviewed in December 2025. The agency objected to product images that made MEDVi appear to be the compounder and to claims describing compounded semaglutide and tirzepatide as having the “same active ingredient” as named FDA-approved products. The FDA said the presentation could imply that the compounded products had been evaluated or approved when they had not.
A warning letter is a regulatory notice, not a finding that every MEDVi service or medication is illegitimate. Current MEDVi pages now state that the company does not produce compounded medications, identify pharmacy partners and disclose that compounded products are not FDA approved.
Nevertheless, the letter is relevant to a consumer review because transparent distinctions between the telehealth platform, prescribing provider, dispensing pharmacy and finished medication are fundamental.
Cancellation requires advance action
Members may cancel by emailing customer service or using portal chat, but MEDVi requires the request at least 72 hours before the next billing date. Missing that deadline can result in another charge, with cancellation taking effect during the following cycle.
Monthly charges are generally nonrefundable for the current or previous months. A full refund may be available when a patient cancels within the first 72 hours without receiving services or is medically disqualified. Multi-month subscriptions may receive a refund for future months in which medication has not shipped.
State and laboratory information is limited
MEDVi’s terms say services are available only in certain states and direct consumers to customer support for the current list. The publicly reviewed materials did not provide a definitive nationwide availability table.
We also did not find a universal statement that every GLP-1 applicant must—or need not—complete laboratory testing. Requirements may depend on the clinician, health history and medication. Ask before paying whether labs are required, where they are completed and who pays.
Safety and eligibility considerations
Semaglutide and tirzepatide require individualized clinical evaluation. FDA-approved Wegovy and Zepbound are indicated for specified adults with obesity or overweight and a qualifying weight-related condition, alongside reduced-calorie nutrition and increased physical activity. A telehealth company’s screening criteria may be narrower.
Common adverse effects include nausea, diarrhea, vomiting, constipation and abdominal discomfort. More serious label warnings include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions and serious hypersensitivity. Hypoglycemia risk can increase when treatment is combined with insulin or certain diabetes medications.
Wegovy and Zepbound carry boxed warnings concerning thyroid C-cell tumors observed in rodents. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Both labels also warn of fetal harm during pregnancy.
Compounded injectable products introduce additional practical considerations. The FDA has received reports of dosing errors, including patients drawing substantially more medication than intended from multidose vials. Patients should receive clear instructions specifying the dose in milligrams, the vial concentration, the correct syringe and the corresponding syringe-unit marking.
Severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down or symptoms of a serious allergic reaction require prompt medical attention. Emergency symptoms should not be managed through routine portal messaging.
Who may find MEDVi worth considering?
MEDVi may be worth considering for adults who:
- Prefer fully remote evaluation and follow-up
- Expect to pay cash rather than use insurance
- Are willing to discuss compounded treatment with a clinician
- Want pharmacy fulfillment and shipping coordinated by the platform
- Receive a clear written price that remains competitive after the introductory period
It may not suit people who:
- Want only an FDA-approved brand-name medication at a clearly stated all-inclusive price
- Need extensive insurance authorization assistance
- Want a local in-person clinic or the ability to select any pharmacy
- Are uncomfortable administering medication from a multidose vial
- Need a publicly available state-by-state coverage list before beginning intake
- Prefer a more flexible refund policy
Questions to ask before enrolling
Before entering payment information, ask MEDVi:
- What is the exact name and dosage form of the medication I am purchasing?
- Is it FDA approved or compounded?
- Which pharmacy will prepare and dispense my prescription?
- What is my first charge and my normal recurring charge?
- Does the price stay the same at every dose?
- Are consultation, medication, syringes, alcohol pads and shipping included?
- Is there a separate membership fee?
- Will I have a live video appointment with the prescriber?
- Are labs required, and are they included?
- How quickly can I contact a clinician about side effects?
- What does 24/7 support provide outside normal business hours?
- What happens if the medication, concentration or pharmacy changes?
- What is my next billing date, and how do I obtain written confirmation of cancellation?
- What refund applies if the clinician determines I am not eligible?
Final assessment
MEDVi offers a convenient telehealth framework, multiple medication pathways, publicly named pharmacy partners and potentially competitive self-pay prices for compounded injections. Those are meaningful advantages for consumers who cannot obtain affordable coverage elsewhere.
Its principal weakness is not necessarily the care model itself, but the amount of verification the consumer must complete. Official pages displayed conflicting prices, brand-name medication follows a different cost structure, state availability is not published clearly, and the cancellation deadline can lead to an additional nonrefundable billing cycle. The February 2026 FDA warning letter also makes precise medication and pharmacy disclosure especially important.
MEDVi may be a reasonable option after a clinician determines that treatment is appropriate and the patient receives clear written answers about the formulation, pharmacy, monthly price, dose changes and follow-up process. The lowest advertisement alone is not enough information on which to enroll.
Frequently asked questions
Is MEDVi legitimate?
MEDVi operates as a telehealth administration platform that connects patients with independent medical providers and pharmacies. It publishes company contact information, provider-network disclosures, legal terms and the names of several pharmacy partners. However, legitimacy is not the same as FDA approval: telehealth companies and clinics are not “FDA-approved,” and compounded medications offered through them are not FDA approved.
The FDA issued MEDVi a warning letter in February 2026 concerning earlier marketing and labeling claims for compounded GLP-1 products. Current pages contain clearer compounding disclosures, but consumers should still verify the actual prescriber and dispensing pharmacy.
Does MEDVi prescribe compounded semaglutide and tirzepatide?
MEDVi’s current disclosures say independent OpenLoop clinicians may prescribe compounded GLP-1 products when they determine that treatment is appropriate. The company advertises compounded semaglutide and tirzepatide injections while separately listing brand-name options.
A compounded preparation is not the same product as Wegovy or Zepbound and is not an FDA-approved generic substitute.
How much does MEDVi cost per month?
There is no single reliable public figure across all MEDVi pages. During this review, one official page advertised price-locked compounded semaglutide from $116 monthly and tirzepatide from $166, while another showed injections starting at $179. Other sections contained different figures.
Request a written prepayment summary identifying the medication, first payment, recurring payment, dose-related changes and separate membership charges.
Is medication included in MEDVi’s price?
MEDVi describes medication as included in many compounded subscription pathways. Brand-name Wegovy and Zepbound were displayed under a $99 membership-plus-medication-cost structure, so the answer depends on the selected treatment.
Does MEDVi accept insurance?
The central weight-loss subscription appears to be primarily self-pay. MEDVi’s terms say its affiliated medical providers are out of network and that medication and laboratory services may not be covered. HSA and FSA payments are advertised on some pages.
Dietitian services may involve insurance or copay eligibility, so this benefit should be clarified separately.
Which pharmacy does MEDVi use?
MEDVi lists Triad Rx, Red Rock Pharmacy and Beaker Pharmacy & Compounding as partner pharmacies. The actual pharmacy may depend on the prescription and patient’s state.
Check the pharmacy name and address on the prescription label and verify its license through the appropriate state board of pharmacy. The FDA recommends confirming that an online pharmacy requires a prescription, provides a U.S. address and phone number and makes a licensed pharmacist available.
Can I cancel MEDVi at any time?
You may submit a cancellation request at any time, but MEDVi requires at least 72 hours’ notice before the next billing date to prevent another renewal. Monthly charges are generally nonrefundable once billed.
Keep a dated copy of the cancellation request and ask for written confirmation showing the effective date.
